Oral Presentations 13: Drug Discovery 4 (Cancer)
Tracks
Track 5
| Tuesday, July 14, 2026 |
| 2:30 PM - 4:00 PM |
Speaker
Dr Ammar Khalid
Senior Resident
Jawaharlal Nehru Medical College, Aligarh Muslim University
Repositioning adapalene using pH-responsive nanocarriers for targeted triple negative breast cancer therapy
Biography
Dr. Ammar Khalid is a Senior Resident in the Department of Pharmacology at Jawaharlal Nehru Medical College & Hospitals, Aligarh Muslim University, India. He holds an MD in Pharmacology. His research focuses on clinical Pharmacology, nanomedicine, and anticancer drug development, with a particular interest in nanoparticulate drug delivery systems for improving therapeutic efficacy and safety.
Prof Isabel Sanchez Perez
Universidad Autónoma De Madrid
Mr Jibira Yakubu
Universität Bern (Unibe)
Targeting castration-resistant prostate cancer with selective CYP17A1 inhibition by Seviteronel
Biography
Jibira Yakubu is a PhD candidate in Pediatric Endocrinology and Metabolism at the University of Bern, Switzerland. His work focuses on steroidogenesis, drug discovery, and developing selective CYP17A1 inhibitors for castration-resistant prostate cancer. Jibira is a recipient of the Swiss Government Excellence Scholarship and several international travel awards. He is a student member of ASPET and the recipient of ASPET Young Scientist Travel Award to attend the 20th World Congress of Basic and Clinical Pharmacology.
Dr Camilla Esposito
University Of Naples "federico Ii"
Dr Mariangela Tamburello
University Of Brescia